Form 4: Goosehead Trust Sells $1.9M in Class A Stock

Sentiment:

Insider Transaction Report


A trust associated with Goosehead Insurance's founders, Mark and Robyn Jones, sold approximately $1.9 million in Class A common stock following conversions from Class B shares and LLC Units.

Worse than expectedA trust associated with the founders sold approximately $1.9 million worth of Class A common stock, which can be interpreted as a reduction in insider exposure and potentially signal a less optimistic outlook for the stock.

Summary

  • The Mark & Robyn Jones Descendants Trust 2014 converted 21,391 Class B Common Stock and 21,391 LLC Units into Class A Common Stock on August 14, 2025.
  • On August 14, 2025, the Trust sold a total of 21,391 Class A Common Stock in multiple transactions at weighted average prices ranging from $87.38 to $89.29, totaling approximately $1,873,775.58.
  • On August 15, 2025, the Trust converted an additional 600 Class B Common Stock and 600 LLC Units into Class A Common Stock.
  • Immediately following, on August 15, 2025, the Trust sold all 600 newly converted Class A Common Stock at a weighted average price of $87.01, totaling approximately $52,206.00.
  • All reported transactions were made pursuant to a Rule 10b5-1 trading plan.
  • Following these transactions, the Mark & Robyn Jones Descendants Trust 2014 beneficially owns 7,214,372 Class B Common Stock and 1,766,355 LLC Units indirectly.

Sentiment

Score: 3

Explanation: The sentiment is moderately negative due to significant insider selling by a trust associated with the founders, even though the sales were pre-planned under a 10b5-1 plan. While planned sales are less alarming than reactive ones, they still represent a reduction in insider exposure.

Positives

  • The transactions were conducted under a Rule 10b5-1 plan, indicating pre-scheduled sales rather than reactive selling, which can mitigate negative market perception.

Negatives

  • Significant insider selling by a trust associated with the founders, totaling approximately $1.9 million, could be perceived negatively by the market.

Risks

  • Potential negative market perception due to insider selling, despite the pre-planned nature of the transactions under a 10b5-1 plan.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • The transactions involve the Mark & Robyn Jones Descendants Trust 2014, which is a related party to Mark Evan Jones (Executive Chairman, Director, 10% Owner) and Robyn Mary Elizabeth Jones (Director, 10% Owner), who serve as trustees and whose immediate family members are beneficiaries of the trust.

Stakeholder Impact

  • Shareholders may perceive the insider selling as a negative signal, potentially impacting investor confidence and stock price.

Key Dates

DateDescription
08/14/2025Mark & Robyn Jones Descendants Trust 2014 converted and sold Class A Common Stock.
08/15/2025Mark & Robyn Jones Descendants Trust 2014 converted and sold additional Class A Common Stock.
08/18/2025Form 4 signed by Attorney-in-Fact for reporting persons.

Recommendation

hold

While the insider selling by the Descendants Trust is a negative signal, the transactions were conducted under a Rule 10b5-1 plan, suggesting they were pre-scheduled and not reactive to recent events. This mitigates some of the negative implications. Without additional company-specific financial or operational news, a 'hold' recommendation is appropriate, advising investors to monitor future filings and company performance for clearer directional signals.

Keywords

Goosehead Insurance, GSHD, SEC Form 4, Insider Trading, Stock Sale, Trust, Mark Jones, Robyn Jones, 10b5-1 Plan, Equity Conversion, Class A Stock, Class B Stock, LLC Units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.